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The ﬁelds of both developmental and stem cell biology explore how functionally distinct cell types arise from
a self-renewing founder population. Multipotent, proliferative human neural crest cells (hNCC) develop
toward the end of the ﬁrst month of pregnancy. It is assumed that most differentiate after migrating through-
out the organism, although in animal models neural crest stem cells reportedly persist in postnatal tissues.
Molecular pathways leading over time from an invasive mesenchyme to differentiated progeny such as the
dorsal root ganglion, the maxillary bone or the adrenal medulla are altered in many congenital diseases.
To identify additional components of such pathways, we derived and maintained self-renewing hNCC lines
from pharyngulas. We show that, unlike their animal counterparts, hNCC are able to self-renew ex vivo
under feeder-free conditions. While cross species comparisons showed extensive overlap between human,
mouse and avian NCC transcriptomes, some molecular cascades are only active in the human cells, correlat-
ing with phenotypic differences. Furthermore, we found that the global hNCC molecular proﬁle is highly simi-
lar to that of pluripotent embryonic stem cells when compared with other stem cell populations or hNCC
derivatives. The pluripotency markers NANOG, POU5F1 and SOX2 are also expressed by hNCC, and a
small subset of transcripts can unambiguously identify hNCC among other cell types. The hNCC molecular
proﬁle is thus both unique and globally characteristic of uncommitted stem cells.
INTRODUCTION
Widespread proliferation and progressive fate restriction over
time characterize embryonic development. During and after
neural tube closure in vertebrate embryos, neural crest cells
(NCC) detach from the ectoderm at the boundary between
neural and non-neural epithelia, multiply and inﬁltrate the
mesoderm. The site-appropriate differentiation of NCC is the
result of a combination of extrinsic factors from the embryonic
niche (1,2) and cell-intrinsic properties that modify responsive-
ness to these inﬂuences (3). NCC normally yields neurons and
glial cells of the entire peripheral nervous system (PNS),
pigment cells and endocrine cells (4). In the head, they also
giverisetocephalictendons,cartilage,bone,dermis,meninges,
vascular smooth muscle and adipocytes (5). The original pro-
genitors disappear along with their birthplace as the neural
tube closes and matures. However, such locations as the
enteric ganglia (6), the dorsal root ganglia (7), the hair follicle
(8–10), the tooth (11) and even the bone marrow (12,13)
appear to be later niches for the maintenance of persistent,
oligopotent avian and rodent neural crest-derived stem cells.
Because of its wide range of derivatives and long-term plas-
ticity, the development of the neural crest has been the topic of
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known about the endogenous characteristics of human
(h)NCC, as they mix with other cell types almost immediately.
Genetic errors inﬂuencing hNCC development seem to be the
basis of such common birth defects as congenital heart defects,
Hirschsprung disease (HSCR), labiopalatine clefting or
cancers such as neuroblastoma and pheochromocytoma, col-
lectively known as neurocristopathies (reviewed in 14). We
set out to identify molecular networks that were activated in
an early hNCC population before they dispersed to their
ﬁnal sites of differentiation.
To address this issue, we ﬁrst determined the precise time
window during which hNCC separate from the developing
neural tube. We then derived primary cell lines that self-renew
without a feeder layer and can be propagated and frozen for
many cycles. This had not been accomplished to date with
NCC from any other species. Rather than focus on known
pathways, we examined their entire transcriptome using
SAGE to determine an intrinsic molecular proﬁle. A subset
of transcripts was validated using RT–PCR, immunohisto-
chemistry and in situ hybridization to check representativity.
When compared to published data from murine or avian
counterparts, hNCC activate novel signaling pathways on
top of many evolutionarily conserved modules. Furthermore,
the hNCC transcriptional proﬁle was highly evocative of the
molecular signature of human embryonic stem (hES) cells,
including but not restricted to the expression of the transcrip-
tion factors SOX2, NANOG and POU5F1. These data indi-
cated that after separation from the neuroepithelium, the
plastic hNCC population remains poised to respond to
lineage-inductive cues, using much the same transcriptional
machinery as hES cells to delay differentiation.
RESULTS
Human neural crest cell isolation
In order to study hNCC before they migrated among unrelated
celltypes,weﬁrstdeterminedthestagesduringwhichtheyemi-
grate from the dorsal neuroepithelium. To this end, 31 human
neural tube fragments from embryos with normal trophoblast
karyotype and ranging between Carnegie stages (C) 10 and
C14 were isolated and plated on collagen I-coated culture
dishes for 16 h (Fig. 1A) in conditions similar to those used in
animalmodelsystems(15,16).Cephalicneuraltubes(frompro-
spective diencephalon through the rhombencephalon) yielded a
halo of hNCC spread onto the dish surface between late C10 to
late C12 [23–27 days post-fertilization (dpf); Fig. 1B and C]. A
similar halo formed around lengths of trunk-level neural tube
caudal to somite 5 between the stages C11 and C13 (24–
29 dpf), but not around neural tube fragments taken from
outside these spatiotemporal boundaries (Fig. 1E). The neural
Figure 1. Primary neural crest cells can be isolated from human embryos. (A) Human neural tube (NT) from an embryo at Carnegie stage (C)13. (B) After 16 h,
most hNCC have migrated away from the dorsal NT. (C) The intact NT is detached from the culture dish. (D) An enriched hNCC population remains, pheno-
typically similar to murine or avian NCC. (E) Empirical evaluation of hNCC migration (none to few, some and many) from 31 explanted neural tubes.
Third-order polynomial regressions reﬂect the rostral-to-caudal temporal maturation gradient of the human NT and maturation of NCC. Peaks occur during
C11 at cephalic levels, and during late C12 at rostral trunk levels (segments extending from somites 5 through the last-formed somite pair).
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enriched NCC population with a characteristic, ﬁbroblast-like
morphology (Fig. 1D). Four cephalic and eight trunk-level cell
lines were derived and propagated. Cells remained euploid
and morphologically unchanged after more than 20 passages
and multiple freeze/thaw cycles. The population doubling
timeofhNCCcelllinesis40–48 handdoesnotchangesubstan-
tively after 9 months in vitro.
Using immunohistochemistry, we observed that some
hNCC expressed proteins typical of partially committed pro-
genitors in avian and murine NCC cultures, such as alpha
smooth muscle actin, neural cell adhesion molecule
(NCAM) (Fig. 2A) and glial ﬁbrillary acidic protein (not
shown). We never observed the hNCC derivative-speciﬁc
markers tyrosine hydroxylase or calcitonin; however,
occasional neurons, revealed by neuron-speciﬁc class III beta-
tubulin (TuJ-1) staining, were present in cultures (Fig. 2B).
The SOX9 protein, which is crucial for differentiation of the
full range of NCC derivatives (17), was localized mostly in
the nucleus (Fig. 2C). In contrast, the SOX2 protein, a
marker of both stem cells and uncommitted neuroepithelium
(18), was both nuclear and cytoplasmic (Fig. 2D).
These observations suggest that individual hNCC within a
given cell line are poised at various stages of lineage commit-
ment, as observed in animal models immediately after delami-
nation from the neuroepithelium (19,20).
Serial analysis of gene expression and validation
For complete transcriptional characterization of hNCC, we
used a modiﬁcation of the Serial Analysis of Gene Expression
(SAGE) technique (21) to generate ‘long’ 21 basepair tags,
representing gene transcripts among the total RNA derived
from trunk-level hNCC. These cells have been isolated from
a C13 female embryo with a normal trophoblast karyotype
and passaged seven times at the time of the analysis. Sequen-
cing of 3546 clones yielded 50 500 tags after exclusion of
duplicated ditags (GEO accession GSM207304). Of these,
22 797 were unique tags, representing 8831 transcripts with
distinct UniGene identiﬁers. Of the unique tags, 39% could
not be reliably assigned to known mRNAs.
To validate the SAGE data, we examined the expression of
55 genes identiﬁed as present in the hNCC library using semi-
quantitative RT–PCR (Fig. 3; Supplementary Material,
Fig. S1). Among the transcripts tested, 50 were represented
by tags with very low ( 3) to low (3 , n , 10) abundance,
or less than 0.02% of total transcripts. Nearly all (96.4%)
were conﬁrmed, including all 20 genes with three or fewer
tags (Supplementary Material, Table S1).
Eighteen classical signature RNAs of amniote NCC (22,23)
were expressed in ﬁve different trunk-level hNCC lines,
including the one used for SAGE analysis (N5 in Fig. 3).
These included transcription factors such as FOXD3, MSX1,
SNAI2, SOX9, SOX10 and TWIST, as well as signaling mol-
ecules or membrane-bound receptors such as RET, GJA1,
EDN1, EDNRB, NESTIN, NOTCH1, P75, PDGFA, PDGFB
and PDGFRB (Fig. 3A).
All transcripts tested were present in the ﬁve hNCC lines as
well as in the stage C12–C13 trunk-level neural tubes from
which the NCC emigrate, with the exception of PAX3 and
PAX6, absent from line N3. The embryonic C13 liver bud also
expressed most of these genes. We examined a subset in
cDNA from adult human liver, and again, many were detected
(Fig. 3A). This expression was not artefactual, as PAX6 was
notexpressed bytheliverbud,orMSX1bytheadultliver.Tran-
scripts,suchasPAX3,FOXD3,NESandTWIST,appearedmore
abundant in hNCC than in the embryonic liver, unlike GJA1 or
SMAD2. We conﬁrmed that the sensitivity of the semi-
Figure 2. Protein markers of hNCC indicate a heterogeneously uncommitted phenotype. In vitro, hNCC synthesized (A) a-smooth muscle actin and/or NCAM,
separately and sometimes in the same cells; (B) neuron-speciﬁc beta III tubulin; (C) nuclear SOX9; (D) nuclear and cytoplasmic SOX2; and unpolymerized
GFAP (not shown). Pigment or immunoreactivity to calcitonin or tyrosine hydroxylase was never observed in these culture conditions. Inset: negative
control with non-speciﬁc primary antibody.
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levels by quantitative RT–PCR. PAX3 transcripts were at least
50-fold,andGJA1atleast3-fold,moreabundantinhNCCcom-
pared to the embryonic liver bud, when normalized to ACTB
abundance (Fig. 3B). In addition, three genes unrepresented in
the hNCC SAGE bank and characteristic of differentiated
hNCC progeny (Fig. 3C, CHAT and PHOX2B, sympathetic
neurons; TYRP1, melanocytes) were not ampliﬁed by semi-
quantitative RT–PCR in the original hNCC line used (N5).
However, the sympathetic markers were detectable in line N2
and TYRP1 in line N4.
We ﬁnally examined the spatial expression of a selection of
genes identiﬁed by SAGE using in situ hybridization on
human embryo sections at C13 (Fig. 4). SOX11 and MAZ
code for transcription factors and GJA1 for a critical gap junc-
tion protein; other genes we studied (not shown) include the
transcription factors SOX10 (24), ZEB2 (25) and CHD7 (26)
and HEYL; the receptors encoded by NOTCH2 and FGFR2;
and the cytoskeleton-associated CTNNB1 and MID1 (27). All
were expressed in both the neuroepithelium and NCC, with
the exception of SOX10, which only postmigratory hNCC
appeared to express at C13. In addition, SOX11 (Fig. 4B),
GJA1 (Fig. 4C, F and I) and MAZ (Fig. 4D) were transcribed
by mesodermal derivatives: GJA1 by the pronephros, limb
bud mesenchyme and, like SOX11 and MAZ, the dermamyo-
tome. Endodermal epithelia expressed FGFR2, similar to later
stages (28). All genes tested were, therefore, expressed by
othertissues,notablybythesourceneuroepithelium,inaddition
tohNCCatC13.Asinanimals,SOX10(24)andFOXD3(Fig.3)
appeared to be more expressed by early postmigratory hNCC
than the neural tube.
Overall, these results show that this hNCC SAGE bank
accurately reﬂects the gene activity of line N5. Its transcrip-
tome is generally representative of hNCC isolated in this
manner, although quantitative expression level differences
indicate that hNCC lines may be individually heterogeneous,
as for other stem cell lines. Moreover, the in situ data
conﬁrm that gene transcripts that are present in the N5
Figure 3. Expression validation of the hNCC SAGE bank. (A) Presence in ﬁve distinct hNCC lines (N1–N5) of typical animal NCC gene transcripts, as shown
by RT–PCR. Most of these genes are also expressed in the C12 and C13 human neural tube (T12 and T13) and in the C13 liver bud (L), as well as in the adult
human liver, below. (B) GJA1 (CX43) and PAX3 are expressed more in hNCC than embryonic liver. ACTB expression was used to normalize the data before
calculating the expression ratio of each gene in the ﬁve hNCC lines compared to the C13 liver bud. (C) Choline acetyltransferase (CHAT) and paired-like homeo-
box 2b (PHOX2B) are expressed by sympathetic neurons and tyrosinase-related protein 1 (TYRP1) by melanocytes, both hNCC derivatives: none of the ﬁve
hNCC lines express all three markers while T12/T13/L samples do. (D) Expression in the ﬁve distinct hNCC lines of genes reported in the literature as
highly characteristic of hES cells.
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tative of hNCC gene expression in vivo.
Interspecies NCC transcriptome comparisons
Most genes that are commonly used to characterize NCC in
animal studies are expressed by hNCC as well. Of the 58 tran-
scripts identiﬁed in an early survey of avian NCC cDNAs (23),
95% were also observed in the hNCC SAGE bank; some of
these have many human paralogues (Supplementary Material,
Table S2). A more comprehensive effort using SAGE on
mouse NCC after 2 (mNCSC) and 7 (mNCP) days of
culture (22) identiﬁed approximately 6000 murine gene tran-
scripts. Of these, 67.2% have orthologues in hNCC
(Fig. 5A). However, more than 4000 additional Unigene clus-
ters were present only in the human cells. This correlates with
such phenotypic differences observed in vitro as the adherent
human cell independence from a feeder layer and unlimited
ability (to date) for propagation without large-scale arrest
and differentiation.
The IDEG6 web tool (29) was applied and yielded a list of
more than 6000 genes that were differentially regulated in
hNCC with statistical signiﬁcance compared to the combined
gene list of mNCSC/NCP. Ontological analysis of the differ-
ential group of genes indicated that the most enriched func-
tional categories in hNCC were cell signaling, cell death,
gene expression, cellular growth and proliferation and cell-
cycle regulation (Fig. 5B). Furthermore, genes annotated as
functioning within the insulin, Shh, Wnt and other growth
factor signaling pathways were enriched in the human cells
(Fig. 5C and D).
Cluster and pathway analyses of whole transcriptomes
show similarity between hNCC and embryonic stem cells
In order to assess the global functional signiﬁcance of the
hNCC gene list relative to a variety of other human cell and
tissue types, we undertook average linkage hierarchical clus-
tering of the gene lists, using SAGE transcriptome data from
14 other non-transformed samples. This analysis grouped
hNCC at a distance from tissues derived from other germ
layers, such as the kidney or skeletal muscle, but also from
tissues of embryologically closer lineages, such as adult
Schwann cells (30) or most of the central nervous system.
The closest clustering was observed with hES cell lines
hES3 and hES4 (31), in contrast to human mesenchymal
stem cells (32) (Fig. 6A). One interpretation of these obser-
vations is that transcriptomes cluster cell or tissue types by
progenitor commitment rather than embryological origin.
In line with this interpretation, hNCC express many genes
considered to play essential roles in the maintenance of
multi-/pluripotency. NANOG, POU5F1 (OCT3/4) and SOX2
(33–35), considered emblematic of embryonic stem cells,
are all synthesized by hNCC (Fig. 3D). In humans, we
observe widespread transcription of NANOG and POU5F1 at
pharyngula stages (Fig. 6B–D). Expression remains high in
central and PNSs at C15 (Fig. 6E–G) and C17–18 (Sup-
plementary Material, Fig. S2), but decreases dramatically in
most other somatic tissues. Many other established stem cell
markers such as CD24, FOXH1 and LIN28 are transcribed
by hNCC (Fig. 3D), as are MYBL2, HELLS, EPHA1, GPR23
and PHC1 (36).
SOX2, NANOG and POU5F1 co-occupy and appear to posi-
tively regulate 180 promoter targets in hES cell line H9 (37).
Of these targets, 110 are expressed by hNCC, when compared
with the 98 transcribed by hES3 and/or hES4 (Supplementary
Material, Table S3). The comparison of quantitative transcrip-
tional levels of common co-occupied targets between hNCC
Figure 4. In situ expression of SOX11, MAZ and GJA1 in the human embryo.
(A) Hematoxylin-eosin (HE) stain of caudal trunk-level transverse section at
stage Carnegie (C)13. (B) Adjacent section. Presumptive dermatome, neural
tube excluding ﬂoorplate, pronephros and splanchnopleural mesoderm and
neural crest cells (arrowheads) express SOX11.( C) The same tissues
express GJA1 in a simultaneously hybridized adjacent section. Expression is
higher in the dermatome, dorsal neural tube and migratory neural crest cells
(arrowheads). (D) MAZ is expressed in an adjacent section in most of the
neural tube aside from the ﬂoorplate (indicated as extension of dotted lines),
and lightly in neural crest (arrowheads), dermamyotome and pronephros.
(E) Forelimb-level HE transverse section in separate C13 embryo. (F) GJA1
antisense probe-hybridized adjacent section. Limb bud, dorsal neural tube
and dorsal roots (arrowheads) hybridize more strongly than other tissues,
nearly all of which have some basal GJA1 expression. (G and J) GJA1
sense probe-hybridized adjacent section to previous frame, demonstrating
speciﬁcity of antisense hybridizations. (H) Rostral trunk-level HE section of
same embryo as in (A–D). (I) GJA1 is highly expressed in the dorsal
neural tube, the dorsal roots and ganglia, the dermatome and the splanchno-
pleural mesoderm, with basal expression in all other tissues of the section
as compared with (J). Abbreviations: aer, apical ectodermal ridge; am,
amnion; cœ, cœlom; cv, cardinal vein; da, dorsal aorta; dC, duct of Cuvier;
dr/g, dorsal root more or less in plane of ganglion; dt, dermatome; g, gut;
la, left atrium; lb, limb bud; lv, liver bud; my, myotome; ncc, neural crest
cells; nd, notochord; nt, neural tube; pn, pronephros; scl, sclerotome; spl,
splanchnopleura; sv, sinus venosus. Bar ¼ 250 mm.
Human Molecular Genetics, 2008, Vol. 17, No. 21 3415andhES3/4showsthatlevelsofthese genesaregloballysimilar
among these three cell lines but differ from bone marrow- or
umbilical cord-derived mesenchymal stem cells, adult liver or
lung (Fig. 6H). Finally, among 280 genes considered to be
stem cell-speciﬁc after comparison of seven genetically
independent hES cell lines (38), 120 are co-expressed by
hES3/4 and hNCC (Supplementary Material, Table S4).
Identical broad-category molecular networks were statisti-
cally over-represented (P , 0.001) in hES and hNCC SAGE
libraries (Supplementary Material, Fig. S3), although this
Figure 5. Human and mouse neural crest transcriptomes have much in common but are also species-speciﬁc. (A) Venn diagram with common and speciﬁc genes
to hNCC, mouse (m)NCSC (early cultures) and mNCP (later cultures) as described by Hu et al. (22). (B and C) Functional annotation of those hNCC genes
differentially expressed (P , 0.001; Fisher’s exact t-test with Benjamini–Hochberg correction for multiple testing) with respect to the combined set of
m(NCSCþNCP). (B) Statistically over-represented functional groups in hNCC with number of molecules assigned to a given group over each bar. (C)
Under- and over-expression of genes assigned to individual pathways in hNCC relative to the mouse represented in green and red, respectively. White represents
those members of a category absent from one or the other dataset. (D) Schematic view of individual components of part of the Notch pathway from (C) with the
same color convention, as expressed in hNCC. In contrast to mNCSC/mNCP, hNCC express many Notch ligands, receptors, co-activators, effectors and tran-
scriptional targets. Abbreviations: a, cell signaling; b, cell death; c, gene expression; d, growth and proliferation; e, cell cycle; f; cytokinesis; g, nervous system
development and function; h, cell morphology; i, cell–cell interaction; j, embryonic development; k, hematological system development and function; AA, eico-
sanoids; EGF, epidermal growth factor; ERK, Microtubule-associated protein kinases; hNCC, human neural crest cells; IGF1, insulin-related growth factor 1; IR,
insulin receptor; ITG, integrins; mNCP, mouse neural crest progenitors; mNCSC, mouse neural crest stem cells; NRG, neuregulins; NT, neurotrophins; PI3K,
Phosphoinositide 3-kinases; SHH, sonic hedgehog; TGFb, transforming growth factor beta family; TLR, Toll-like receptors; VEGF, vascular endothelial growth
factors.
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logies. More detailed analysis showed that human NCC and
ES cells synthesized 840 mRNAs in common that are anno-
tated as involved in ‘transcriptional regulation’ (Supplemen-
tary Material, Table S5). Of these, 114 transcription factors
(Supplementary Material, Table S6) included targets of
characterized growth factor (SMAD1/3/4/5, CREBBP,
STAT1/3, SRF, JUN, CUTL1, ELK1 and FOS) and steroid
hormone (RARA, RXRA, RXRB, RARG, NR1D2 and VDR) sig-
naling pathways. When transcriptional regulation genes were
also expressed by the multipotent BM-MSC or the liver,
there was wide ﬂuctuation in expression levels between cell
types, which was not the case for the hNCC–hES comparison.
The second most over-represented classiﬁcation of gene
products common to hNCC and hES was that of ‘cellular pro-
liferation and growth’. Within the category, hNCC, hES3 and
hES4 expressed 1088 genes in common (out of 1350, 1712 and
1601, respectively, in this category) that regulate cell cycle
progression and encode growth factors, hormone and cytokine
receptors and their effectors (Supplementary Material,
Table S7). In all stem cell lines, more members of the hedge-
hog, ﬁbroblast growth factor, Wnt, transforming growth
factor-b, Notch and vascular endothelial growth factor signal-
ing pathways are expressed than in the adult liver transcrip-
tome. In physiological contrast, only the BM-MSC and liver
transcribed a statistically signiﬁcant proportion of genes that
are classiﬁed as part of the complement system (Supplemen-
tary Material, Fig. S3).
Quantitative transcript levels of individual components
assigned to statistically over-represented signaling pathways
are similar among the hNCC, hES3 and hES4 cells relative
to the MSC, liver and lung (Fig. 7), as indicated by the
cluster analysis (Fig. 6A). In fact, such pathways are function-
ally interconnected, as demonstrated by the expression of
many intracellular components assigned to both integrin-
related and IGF-related cascades (Fig. 8).
In summary, at multiple levels, the type and proportional
representation of RNA transcripts in hNCC are most similar
to the least committed cell types included in these analyses,
the hES cell lines.
Neural crest-speciﬁc marker proﬁle
To ﬁlter for those transcripts most speciﬁc to hNCC that might
reside in postnatal tissues, we performed tissue preferential
expression (TPE) analysis (39), using SAGE data from 14
other normal postnatal human cells or tissues, initially exclud-
ing hES cells. TPE is based both on the number of tissues in
which a gene is present (range of expression) and its quantitat-
ive expression level in each. A score for each gene was plotted
against the number of times that each gene was observed
among the list of all tissues (Supplementary Material,
Figure 6. Pluripotent stem cell markers are expressed by uncommitted hNCC. (A) Hierarchical cluster dendrogram of hNCC-expressed transcript list compared
to 14 publicly available, normal human tissue SAGE banks (uncentered correlation, average linkage). The global transcriptome of hNCC is most similar to two
hES cell lines (hES3 and hES4) relative to the transcriptomes of the substantia nigra (subst nig); mesenchymal stem cells from the umbilical cord (umb MSC) or
bone marrow (BM-MSC), highly similar to each other by this analysis; pulmonary epithelium (lung ep), Schwann cells in vitro, prostate, sciatic nerve, cerebel-
lum, brain white matter (wh matt), kidney, liver or skeletal (sk) muscle. Correlation coefﬁcients are indicated in red. (B) Expression of NANOG mRNA in trans-
verse section of human Carnegie stage 13 (C13) embryo (cf. Fig. 4H) is discrete but present in neural tube, neural crest cells in the dorsal root (arrowhead) and
dermatome, when compared with a sense probe hybridized adjacent section (C). (D) Expression of POU5F1 in simultaneously hybridized adjacent section is
more visible in equivalent structures, and seems to have a widespread basal expression in all tissues. (E) NANOG expression at C15 (cf. Fig. 9F and G). After a
few days’ growth, expression is more distinct in the proliferating neuroepithelium, dorsal root ganglia, the motor horns, stomach, sympathetic ganglia, liver bud
and migrating myotome cells. (F) Adjacent section hybridized with sense probe. (G) POU5F1 is expressed in a similar pattern. Both NANOG and POU5F1
transcripts appear to be excluded from the roofplate of the neural tube at this stage (extension of dotted lines). (H) Heat map of target genes whose promoters
can be co-occupied by SOX2, NANOG and POU5F1 in hNCC, hES3, hES4, BM-MSC, UC-MSC, adult liver and lung cells, respectively. White stands for a
tags-per-million (tpm) value equal to 0, light blue for 1   tpm   49, dark blue for 50   tpm   100 and magenta for tpm value .100. Global modulation
is similar in hNCC and hES3/4 compared to the more distantly clustered cell types; for example, SOX2 itself, although other genes are expressed differentially,
such as ZIC1 or ZFHX1B. Abbreviations: da, dorsal aorta; dm, dermamyotome; drg, dorsal root ganglion; es, stomach; lv, liver; mn, mesonephros; nt, neural
tube; sg, sympathetic ganglion.
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range ¼ 15 correlated their ubiquitous expression with the
ﬁnding that 60% are structural ribosome constituents or pro-
teins involved in primary cellular energy metabolism.
The hNCC most-speciﬁc gene list (range ¼ 1) contained
119 transcripts (Supplementary Material, Table S8), many of
which are involved in the regulation of transcription and
DNA-histone packaging. Parallel analyses of hES3 or hES4,
excluding the other hES cell line and hNCC, demonstrated
that 48 of these 119 also had a TPE range ¼ 1 in each.
Thus, across the 16 distinct human cell and tissue types exam-
ined, 43 low-abundance transcripts were most speciﬁc to
hNCC (Table 1) and 27 of these are also transcribed by
C12–13 embryonic neuroepithelium (results not shown), in
keeping with other expression data (Figs 3, 4, 6 and 9).
Of the 20 TPE ¼ 1 genes that are currently annotated by
Gene Ontology, half encode DNA-binding proteins such as
DBX2 (40), ZNF157, HOXC5 and TIGD3. We conﬁrmed
hNCC expression of HOXC5, C2ORF63 (FLJ31438),
ZNF417 and AMIGO3 by RT–PCR in ﬁve distinct hNCC
lines (Fig. 9A). Adult liver also transcribes ZNF417 and
AMIGO3, although transcript abundance was below the
threshold of SAGE detection in a publicly accessible liver
bank with 66861 short (10 bp) tags, accounting for the TPE
result. HOXC5 expression pattern in whole human embryo
sections (Fig. 9B–G) correlates well with trunk-level neural
tube expression (rhombomere 8 and caudal) noted in mouse
embryos (41). Indeed, HOXC5 is one of only three genes
from this list whose orthologue is transcribed by mNCSC/
NCP (22), although many of the other human transcripts are
novel and do not yet have validated orthologues. HOXC5 is
expressed by hNCC entering the dorsal root, within the
neural tube, in hypaxial muscle precursors (Fig. 9D) and in
limb mesenchyme (Fig. 9B). Transcripts are more easily
detected at C15 in the ventral motor horns, median ventricular
zone and ﬂoorplate, dorsal root ganglia, as well as in the
forming vertebral bodies, muscle precursors and stomach
wall (Fig. 9F).
On the whole, these results show that hNCC can naturally
be distinguished from hES cells by the expression of a
highly speciﬁc and small subset of markers. However, like
hES cells, hNCC keep many molecular characteristics of
their in vivo embryonic phenotype, as well as the capacity
for self-renewal in vitro.
DISCUSSION
The stem cell proﬁle of hNCC
The shared transcriptional signature between hNCC and hES
cells was startling. Trunk-level NCC in animals have been his-
torically described as relatively oligopotent compared to the
cephalic NCC. However, the extent and onset of trunk-level
NCC lineage restriction remains controversial (42). In vivo,
cartilage and bone, smooth muscle and adipocytes (among
other derivatives) come either from the trunk mesoderm or
the cephalic neural crest. Avian trunk-level NCC have the
Figure 7. Growth factor pathways are similarly activated in hNCC and hES
cells, relative to other cell types. Heat map representing expression levels in
hNCC, hES3, hES4, UC-MSC, BM-MSC, adult liver and adult lung cells of
lists of genes attributed by IP software to various signaling pathways. These
include but are not exclusive to the epidermal growth factor (EGF), ﬁbroblast
growth factor (FGF), insulin-like growth factor (IGF), NOTCH, Sonic hedge-
hog (SHH), transforming growth factor (TGF)-beta, vascular endothelial
growth factor (VEGF) and WNT pathways. Gene symbols for the more abun-
dant hNCC tags are listed on the left, with high concomitant hES expression in
red text. White, tags-per-million (tpm) value equal to 0; light blue, 1   tpm  
49; dark blue, 50   tpm   100; magenta, tpm value .100.
3418 Human Molecular Genetics, 2008, Vol. 17, No. 21ability in vitro to not only give rise to cartilage and bone (3)
and smooth muscle cells (43), but to adipocytes as well (44).
Cartilage, bone, smooth muscle and adipocytes can of course
also differentiate from BM-MSC, as many studies attest.
Interestingly, Takashima et al. (13) have demonstrated that
some murine BM-MSC in fact are seeded by neuroepithelial-
derived NCC. We expected to ﬁnd a closer relationship to
BM-MSC or neural crest derivative transcriptomes than to
hES lines.
Our data, therefore, have some provocative implications for
the use of ‘markers’ in developmental biology. For example,
like in hES lines, some early markers of deﬁnitive embryonic
endoderm (FOXA2, GPC1, TM4SF2 and CXCR4) are found
in the hNCC bank, but not others (SOX17 and HHEX). This
hints that hNCC may have the potential to add new, non-
physiological progeny to the already extensive list of in vivo
derivatives; an overlapping contingent of these genes is
expressed by the fully pluripotent hES3 line (31). However,
under some initial conditions varying the physical matrix,
seeding density and the proportions of exogenous growth
factors (available upon request), we have not yet successfully
oriented hNCC differentiation in vitro. A novel set of con-
ditions that remains to be tested is a medium free speciﬁcally
of blocks to b-catenin signaling and ERK activation, inhibitors
of which are necessary and sufﬁcient for mouse ES cell self-
renewal (45).
The simultaneous transcription of SOX2, NANOG and
POU5F1 is not sufﬁcient to confer ES identity, since we
ﬁnd all three in the hNCC lines. In addition, hNCC express
LIN28, many members of the KLF gene family and MYCN,
MYCL1 and a number of MYC-binding proteins. Forced
expression of various combinations of members of two of
these gene families with POU5F1 and SOX2 have all led to
pluripotent stem cell induction from human somatic cells
(46,47).
Somatic cells from the pharyngula-stage embryo, such as
these hNCC, may have a closer ground state to a pluripotent
phenotype than do adult somatic cells, with their very low fre-
quency of inducibility. With respect to ‘pluripotency’ markers,
chicken embryonic neuroepithelium and neural folds express
Sox2 from stages preceding NCC formation (48). In contrast
with our ﬁndings in human embryos, in situ hybridization
does not demonstrate the presence of Nanog transcripts at
neurula/pharyngula stages of mouse development (49).
However, Pou5f1 (Oct3/4), although best known for its
expression by the murine germ-cell lineage and cell lines
derived therefrom, is also expressed by both embryonic ecto-
derm and neuroepithelium (50), and it plays a permissive role
in all germ layers in zebraﬁsh (51). We interpret the similar
molecular signature of hNCC and hES cells as an unprecedent-
edly detailed example of a homologous developmental process
(52) underlying the state of multipotency. Further studies will
be necessary to test the ability of hNCC in vivo to differentiate
into functional cells representative of any or all tissue types
with a teratoma assay; a better test would be their ability to
contribute to chimeras, in particular to the germ line of such
chimeras, before claims of pluripotency could be supported.
However, for ethical and practical reasons, such experiments
are impracticable by our laboratories.
Comparative embryology
Inhumans, asinother vertebrates, there is alag intime between
the peak migration windows for NCC from the cephalic versus
Figure 8. Schematic view of part of the IGF-1 and integrin signaling pathway genes transcribed by hNCC. Pink-tinted symbols are genes expressed by hNCC,
and documented physical interactions exist for each edge depicted.
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Symbol hNCC
(tpm)
GO annotation EST sources (NCBI)
Function Process Component Embryo
a Foetus
b Adult
c
AMIGO3 20 Protein binding Cell adhesion Membrane 0 1 7
C10ORF85 20 nd nd nd 0 3 1
DKFZP761N09121 20 Protein transporter activity Intracellular vesicle-medicated
transport
Golgi-associated
vesicle
nd nd nd
DNAH1 20 Microtubule motor activity Ciliary or ﬂagellar motility Axonemal dynein
complex
27 8 4
FAM70B 20 nd nd Membrane 0 4 12
FLJ16139¼DBX2 20 Transcription factor activity Regulation of transcription,
DNA-dependent
00 2
FLJ20345¼MKS1 20 nd nd nd 5 19 52
FLJ31295¼ZNF641 20 DNA binding, metal ion binding Regulation of transcription,
DNA-dependent
Intracellular 4 1 43
FLJ31438 40 nd nd nd 1 9 27
FLJ40126¼C12orf40 20 nd nd nd nd nd nd
GABRR3 20 GABA-A receptor activity Synaptic transmission Postsynaptic
membrane
nd nd nd
HIST1H1D 20 DNA binding, protein binding Nucleosome assembly,
chromosome biogenesis
Nucleosome,
chromosome
01 1
HIST1H2BE 20 nd nd nd nd nd nd
HIST1H2BJ 20 DNA binding Nucleosome assembly,
chromosome organization
Nucleosome,
chromosome
01 2
HIST1H3B 20 nd nd nd nd nd nd
HIST1H4F 20 nd nd nd nd nd nd
HMFN0672¼C8orf80 40 nd nd nd 0 2 0
HOXC5 99 Transcription factor activity Regulation of transcription
from RNA pol II promoter
Nucleus 1 8 10
HOXD9 20 RNA pol ll transcription factor
activity
Regulation of transcription,
DNA-dependent
Nucleus 0 22 20
KCNG2 20 Potassium channel activity Ion transport, potassium ion
transport
Membrane nd nd Nd
KIAA1822L 20 Catalytic activity nd nd 0 1 4
LOC255177 20 nd nd nd 0 0 0
LOC352909¼C19orf51 20 nd nd nd 4 27 56
LOC400340 20 nd nd nd nd nd nd
LOC401021 20 nd nd nd nd nd nd
LOC401485 20 nd nd nd nd nd nd
LOC440502 20 nd nd nd nd nd nd
LOC440993 20 nd nd nd nd nd nd
LOC441053 20 nd nd nd 0 23 177
LOC493860¼CCDC73 20 nd nd nd nd nd nd
MGC16372¼C2orf39 20 nd nd nd 0 5 6
MGC48915¼C1QTNF9 20 nd Phosphate transport Cytoplasm
PP3856¼NAPRT1 20 Nicotinate
phosphoribosyltransferase
Pyridine nucleotide
biosynthetic process
nd 1 9 64
PRDM12 59 DNA binding, metal ion binding Regulation of transcription,
DNA-dependent
Nucleus 0 2 0
PRH1 20 nd nd nd 1 4 353
RHEBL1 20 GTP binding Small GTPase mediated signal
transduction
Intracellular 0 0 6
SH3GLP2 20 nd nd nd nd nd nd
STOX2 20 nd nd nd nd nd nd
TIGD3 20 DNA binding Regulation of transcription Nucleus 0 5 4
UCN 20 Neuropeptide hormone activity G-protein coupled receptor Extracellular region 0 0 12
WNT7A 40 Receptor binding, signal
transducer activity
Wnt receptor signaling
pathway
Extracellular region 0 4 8
ZNF 157 20 DNA binding, metal ion binding Regulation of transcription,
DNA-dependent
Nucleus 0 0 0
ZNF417 40 DNA binding, metal ion binding Regulation of transcription,
DNA-dependent
Nucleus 1 4 13
Genes most speciﬁc to hNCC as shown by TPE analysis (range value ¼ 1) and not expressed in hES cells.
aCount of human expressed sequence tags, out of 125 776 total from embryonic tissues.
bCount of human expressed sequence tags, out of 557 809 total from fetal tissues.
cCount of human expressed sequence tags, out of 1 899 694 total from postnatal tissues (UniGene’s EST ProﬁleViewer).
3420 Human Molecular Genetics, 2008, Vol. 17, No. 21the trunk levels. Species differences appear in the uncoupling
of migration from that of neural tube closure. We observed
that the majority of hNCC migrate after neural fold apposition
along the body axis and continue to do so after fusion, similar
to other amniotes and amphibia but in contrast to the ﬁsh (4).
Recent anatomical observations imply that the ﬁrst cranial
hNCC begin migrating well before closure (53), with fusion
catching up with hNCC delamination by the hindbrain.
These two processes use common molecular mechanisms for
the rearrangement of the actin cytoskeleton necessary for
both convergent extension (54) and epithelio-mesenchymal
transition (EMT)/migration (55), respectively.
Many gene transcripts found in avian or mouse migratory
NCC are present in hNCC under their conditions of isolation.
However, as many or more appeared to be unique to either
mouse or to humans. A larger proportion still was expressed
differentially to a statistically signiﬁcant level. This is
perhaps unsurprising considering the phenomenal plasticity
of the neural crest lineage and its capacity to engender such
diverse and species-speciﬁc structures as the turtle shell (56)
and the deer antler (57). A greater total tag count in the
hNCC bank may also have contributed to the detection of
rarer transcripts relative to the mouse SAGE banks.
Among the human-speciﬁc expressed genes were a number
that fell into characterized signaling pathways from other cel-
lular systems, not necessarily suspected to have a role in the
hNCC lineage. One phenotypic difference between human
and animal NCC is that mouse cells are described to have a
self-renewing potential limited to some weeks (22) while
hNCC, cultivated without a feeder layer, can survive many
months in our conditions without division arrest or large-scale
differentiation. Animal NCC populations appear to be a hete-
rogeneous collection of partially committed progenitors in
vitro, be they of avian (16,58) or murine (15,59) origin.
Henion and Weston (20) concluded that nearly half of the
avian NCC from the trunk level was fate-restricted precursors
generating a single cell type. Cluster analysis bears out our
empirical observations by grouping the cultured hNCC tran-
scriptome most closely with pluripotent embryonic stem
cells, rather than with any committed neural crest progeny.
Novel hNCC markers
We have applied TPE to generate two detailed sub-proﬁles:
that of highly speciﬁc hNCC markers and another of shared
hNCC-hES molecules, which may be applied in the future to
cell sorting. Currently, attempts to isolate NCC-like progeni-
tors from human skin have relied on external phenotypic
characteristics (10,60). Cell sorting has been used to enrich
for rat NCC with tissue-restricted stem cell capacities;
however, the marker employed was an elegant but artiﬁcial
construct only applicable to genetically modiﬁed rodents
(42). As identiﬁed, the rat cells had already become
lineage-restricted in their peripheral niche.
Individual transcripts in the most-speciﬁc TPE list clearly do
not signify NCC identity. The combination of all or a subset of
them,andperhapstheirquantitativelevels,mayhoweverbesuf-
ﬁcient to uniquely identify hNCC with a similar lack of fate
commitment. One advantage of the SAGE approach is illus-
trated by the fact that 39% of unique tags in the hNCC library
could not be reliably assigned to known mRNAs. Some of this
ambiguity must be due to sequencing errors or polymorphisms
(61), but a large subpopulation probably corresponds to novel
transcripts expressed in hNCC. One indication is that 296
(1.3%) of these tags mapped readily to recently predicted
natural antisense RNA (naRNA)sequences(62)(Supplementary
Figure 9. Prediction of mRNA subset speciﬁc to hNCC. (A) RT–PCR for four
genes with TPE score¼1 shows that it is possible to amplify AMIGO3 and
ZNF417 from an adult human liver, although below the level of detection
by a publicly available SAGE bank from another sample. HOXC5 and
C2ORF63 were speciﬁc to most or all hNCC lines. (B) In situ hybridization
to HOXC5 demonstrates expression in the human embryo at Carnegie stage
13 (C13; cf. Fig. 4E) in most cells at the level of the limb bud, with higher
levels in the neural tube, the neural crest (arrowhead), the limb mesenchyme
and the rest of the somatopleural mesoderm. (C and E) Sense probe-
hybridized adjacent transverse sections to previous frames demonstrate
speciﬁcity of signal. (D) HOXC5 in a different C13 embryo section taken at a
more rostral transverse level than in (B); expression appears reduced in the
ﬂoorplate relative to the rest of the neural tube. (F) At C15 (cf. Fig. 6E–G),
HOXC5 is expressed by the developing vertebra, muscle precursors, ventricular
zone of the neural tube and motor horns; it is also transcribed by all other tissues
in this section when compared with the sense-hybridized adjacent section (not
shown). (G) Adjacent HE section. Thus, markers are only speciﬁc to a particular
cell type within a given spatiotemporal context. Abbreviations: cœ, cœlom; da,
dorsal aortae; h, heart; hm, hypaxial muscle precursors; lb, limb bud; lv, liver;
m, muscle; nd, notochord; nt, neural tube; vt, vertebra.
Human Molecular Genetics, 2008, Vol. 17, No. 21 3421Material, Table S9). Others may correspond to primary
microRNA transcripts. New membrane proteins will be
particularly helpful for ﬂuorescence-activated cell sorting
experiments.
The results presented here will help in reliably isolating
highly multipotent NCC from pre- or postnatal human
tissues. These cells could be used for transplantation therapies
in such diseases as peripheral demyelinating neuropathies or
HSCR.
Candidate genes for human disease
As a point of comparison between early hNCC and their
normal or pathological progeny, this hNCC signature can elu-
cidate the molecular underpinnings of additional diseases.
Many genes already known to cause human neurocristopathies
are expressed in the hNCC SAGE library, including PAX3 and
SOX10 (Waardenburg syndrome), KIT and SNAI2 (piebald-
ism), MSX1 (tooth agenesis/orofacial cleft), CHD7
(CHARGE syndrome), and ECE1, EDNRB, ITGB1,
KIAA1279 and ZEB2 (HSCR). Some neurocristopathies arise
from the disruption of hNCC migration and/or the EMT
from the neuroepithelium (14). Currently, a limited number
of such EMT-associated disease genes include EFNB1,
FOXC1, LAMA5, SEMA3C and SNAI2 and are all known
and expressed in this hNCC SAGE bank. The examination
of functional modules such as EMT may be a fruitful strategy
to identify new neurocristopathy genes. For example, the
SNAG corepressor domain of SNAI2, found only in vertebrate
homologues of Drosophila snail, has recently been implicated
in Xenopus NCC speciﬁcation within the neuroepithelium
(63). Potential co-repressors JUB, LIMD1, TRIP6, WTIP and
ZYX are all transcribed by hNCC, demonstrating the utility
of such species- and tissue-speciﬁc expression banks for inte-
grating dispersed functional data and generating new hypo-
theses for candidate genes to correlate with known disease
loci. The use of our self-renewing hNCC lines for functional
analyses of such candidate genes is a particularly appealing
application of their potential in all senses of the word.
MATERIALS AND METHODS
Human embryos
Human embryos were collected from pregnancies legally ter-
minated using the meﬁprestone protocol, in concordance with
French bioethics law 2004-800 and with the approval of the
Necker hospital ethics committee.
hNCC isolation
Whole human embryos under 8 weeks’ gestation were dis-
sected away from their annexes in ice-cold phosphate-buffered
saline (PBS). A piece of chorionic villus was treated immedi-
ately for 1 h in colchicine-DMEM before 10 min hypotonic
shock in 0.075 M KCl and 1:3 acetic acid:ethanol ﬁxation for
three changes of 10 min each. Nuclei were spread, stained
for G-bands and chromosomes counted according to standard
karyotype procedure. Cephalic neural tube segments were
isolated by cutting perpendicular to the long axis behind the
optic vesicles and again at somite pair 5, and trunk-level
neural tube segments from somite 5 to the last available
somite pair. Other tissues were trimmed away and the segment
placed in 6 mg/ml pancreatin (Sigma P3292) in PBS for 7 min.
Pieces were transferred into clean PBS to tease away all
tissues, including the tightly adherent notochord and ectoderm,
from neural tubes. The enzymatic reaction was stopped and
neural tubes maintained thereafter in complete hNCC medium.
Initial hNCC migration and replating on collagen I-coated
plates (Becton Dickinson) used the following medium:
Dulbecco’s Modiﬁed Essential Medium/BGJb (Fitton-Jackson
modiﬁed)/Ham’s F12 [3:1:6 v/v, Sigma] supplemented with
12% complement-inactivated fetal calf serum (PAN
Biotech); 1  penicillin/streptomycin (Invitrogen); 2 mM glu-
tamine, 10 mM HEPES, 0.1 mg/ml hydrocortisone, 10 mg/ml
transferrin, 0.4 ng/ml T3 (3,3,5-thio-iodo-thyronine), 10 pg/
ml glucagon, 100 pg/ml epidermal growth factor, 1 ng/ml
insulin and 200 pg/ml ﬁbroblast growth factor 2 (Sigma).
Tubes were transferred to the centre of 35 mm collagen-I
dishes with 300 ml medium and placed in humidiﬁed CO2
incubators at 378C for 8 h to facilitate adhesion. One milliliter
of medium was then added for a further 16 h, during which
cells migrated onto the plastic. Tubes were removed with a
ﬁre-polished Pasteur pipette and primary cultures allowed
to grow for another day before ﬁrst replating. Passages
were obtained by dissociation from plates using 3 min
trypsin-EDTA treatment and complete hNCC medium to
stop the reaction. No feeder layer cells or other adjuvants
(e.g. leukemia inhibitory factor and embryo extract) were
necessary for long-term maintenance for up to 9 months.
Karyotyping
Standard G-band karyotypes were performed on 10 meta-
phases from fresh trophoblast and thawed embryonic hNCC.
Immunocytochemistry
Cells were prepared for immunostaining by ﬁxation in 4%
paraformaldehyde for 20 min and subsequent permeabilization
for 25 min with 0.1% Tween-20 in PBS. Primary antibodies:
monoclonal anti-a-smooth muscle actin (Cy3-conjugated,
Sigma C6198), monoclonal anti-neuron speciﬁc class III
beta-tubulin (TuJ1) (R&D Systems), polyclonal anti-NCAM
(Chemicon), polyclonal anti-tyrosine hydroxylase (Chemicon
AB1542), polyclonal anti-calcitonin (Chemicon AB910),
monoclonal anti-human glial ﬁlament acidic protein (GFAP)
(Cymbus Biotechnology), polyclonal anti-SOX9 (Chemicon
AB5535) and polyclonal anti-SOX2 (Abcam AB15830).
Nuclei were counterstained (Hoechst).
Sage library construction and RT–PCR
Standardprotocols (64,65)were usedtoconstructaLongSAGE
library from 5 mg total RNA (RNeasy Mini, Qiagen) prepared
from trunk-level hNCC of a C13 embryo after 7 passages. In
brief, NlaIII and MmeI restriction enzymes (New England
Biolabs) were used for tag generation. After 3 h self-ligation,
100 at 658C and 20 on ice, puriﬁed concatemers were
subsequently cloned into pZERO-1 (Invitrogen). Individual
3422 Human Molecular Genetics, 2008, Vol. 17, No. 21clones were selected and sequenced. LongSAGE tags (17 bp)
were extracted from raw sequence data using SAGE2000
version 4.5 Analysis Software. The LongSAGE tag database
was linked to the SAGE Map database (NCBI) and the ACTG
web tool (http://retina.med.harvard.edu/ACTG/) (66) for tag-
to-gene mapping. The original SAGE data in this paper are
available from the NCBI Gene Expression Omnibus (GEO)
under accession number GSE8368.
Total RNA from ﬁve individual hNCC lines, C12 and C13
isolated neural tubes (four and two pooled, respectively) and
four pooled C13 liver buds were prepared using the RNeasy
Mini kit (Qiagen); total adult human liver RNA was obtained
from Clontech. After reverse transcription (Applied Biosys-
tems), PCR ampliﬁcations for gene validations were per-
formed in a ﬁnal volume of 25 ml using 50 ng of
Nanodrop-quantiﬁed cDNA and 35 ampliﬁcation cycles. For
quantitative RT–PCR, LightCycler Fast Start DNA
Master
PLUS SYBR green I (Roche) was used according to
the manufacturer’s protocol. ACTB was used to normalize
data for the calculations of DCt. Primers are listed in Sup-
plementary Material.
In situ hybridization
Intact, euploid human embryos were processed for in situ
hybridization as described elsewhere (67). Primers used for
DNA matrix synthesis by PCR are listed in Supplementary
Material.
Statistical analyses
Hierarchical clustering was performed to create a multi-level
binary cluster tree, linking tissue or cell types by similarity.
In addition to the hNCC bank, data were obtained from 11
banks of the Gene Expression Omnibus (http://www.ncbi.
nlm.nih.gov/geo/): GSM676 (brain white matter), GSM761
(cerebellum), GSM762 (lung), GSM708 (kidney), GSM785
(liver), GSM824 (muscle), GSM31931 (substantia nigra),
GSM41359 (hES3), GSM41362 (hES4), GSM48250 (sciatic
nerve), GSM48251 (Schwann cells in vitro); one from the
Cancer Genome Anatomy Project http://cgap.nci.nih.gov/
SAGE/SAGELibraryFinder:SAGE_Prostate_normal_B_2
(prostate); and for bone marrow and umbilical cord vein
mesenchymal stem cells, data from the website http://bit.
fmrp.usp.br/msc_tags/ (32) (current requests for raw data
directly to authors). Counts from all SAGE libraries were nor-
malized to a total of one million for input to Cluster 3.0 free-
ware (http://www.geo.vu.nl/~huik/cluster.htm) (68). Average
distances were classed to link samples into clusters. In order
to compare and validate the robustness of the results, Eucli-
dean (squared), Pearson (uncentered) and Spearman rank
numeric scales were all computed to calculate average dis-
tances. The dendogram was made with TreeView freeware
(http://jtreeview.sourceforge.net/). Data were functionally
annotated using Pathways Analysis 5.0 (Ingenuity Systems)
and DAVID software (69).
The TPE analysis (39) was performed with the following
additional samples (GEO or CGAP accession numbers):
Bone marrow (GSM14784), placenta (GSM14749), muscle
(GSM 824), liver (GSM785), stomach (SAGE_Stomach_nor-
mal_MD_13), kidney (GSM708), lung (GSM762), breast
(SAGE_Breast_normal_myoepithelium_AP_myoepithelial1),
prostate (SAGE_Prostate_normal_B_2), ovary (SAGE_Ovary_
normal_CS_HOSE_4), endometrium (SAGE_Uterus_endome
trium_normal_CS_DI1), brain white matter (GSM676), whole
cerebellum (GSM761) and whole spinal cord (SAGE_Spinal_
cord_normal_B_1).
For the detection of statistically differentially expressed
genes, we used the IDEG6 web tool (http://telethon.bio.
unipd.it/bioinfo/IDEG6_form/). The Fisher exact test (signiﬁ-
cance threshold 0.05) was used with a Bonferroni correction
to account for multiple testing (29).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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